Entera Bio Ltd

Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
Returns
Key stats
Analyst consensus
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Financials
About Entera Bio Ltd
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.
Frequently asked questions
To buy Entera Bio Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Entera Bio Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Entera Bio Ltd is ENTX. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Entera Bio Ltd has its primary listing on NASDAQ (Small cap). You can trade Entera Bio Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Entera Bio Ltd is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Entera Bio Ltd as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Entera Bio Ltd or others.